Psychiatry and Neurology, Neurology · New York, NY
NPI
1780771873
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
520 E 70th St # Starr-607
New York, NY, 10021
Phone (212) 746-2320
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
1,031 services
Medicare patients, 2024
484
Average age 75
Drug cost, 2024
$1.7M
583 prescriptions
Company payments, 2025
$3,000
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Rubin was code 95886 (electrical nerve conductivity), 437 times for 235 patients. In total Michael Rubin billed 1,031 services in 16 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95886 Electrical Nerve Conductivity | Facility | 437 | 235 | $40.31 | $18K |
| 99204 Office E&M - New | Office | 155 | 155 | $140.61 | $22K |
| 99214 Office E&M - Established | Office | 99 | 89 | $115.83 | $11K |
| 95908 Electrical Nerve Conductivity | Facility | 77 | 77 | $58.26 | $4,486 |
| 95909 Electrical Nerve Conductivity | Facility | 72 | 72 | $71.32 | $5,135 |
| 95910 Electrical Nerve Conductivity | Facility | 63 | 62 | $93.27 | $5,876 |
| 99203 Office E&M - New | Office | 44 | 44 | $95.88 | $4,219 |
| 99213 Office E&M - Established | Office | 25 | 24 | $69.84 | $1,746 |
| 95911 Electrical Nerve Conductivity | Facility | 12 | 12 | $110.09 | $1,321 |
By year: 2022 $76K for 1,056 services; 2023 $76K for 1,064 services; 2024 $76K for 1,031 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael Rubin prescribed most often to Medicare patients was Gabapentin, with 149 prescriptions and refills. In total Michael Rubin wrote 583 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 149 | 357 | 63 | $2,810 |
| Mycophenolate Mofetil Generic | 59 | 127 | 14 | $17K |
| Duloxetine Hcl Generic | 41 | 79 | Under 11 | $850 |
| Prednisone Generic | 36 | 38 | Under 11 | $320 |
| Pyridostigmine Bromide Generic | 36 | 84 | 14 | $1,904 |
| Pregabalin Generic | 28 | 28 | Under 11 | $587 |
| Firdapse Amifampridine Phosphate | 27 | 27 | Under 11 | $1.5M |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 25 | 25 | Under 11 | $311 |
| Amitriptyline Hcl Generic | 21 | 57 | Under 11 | $255 |
| Azathioprine Generic | 16 | 24 | Under 11 | $662 |
| Carbamazepine Er Carbamazepine | 12 | 32 | Under 11 | $2,422 |
| Levetiracetam Generic | 11 | 11 | Under 11 | $112 |
Brand drugs: 65 claims; generic drugs: 518 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Rubin $3,000 ($3,000 in general payments such as food, travel and fees) from 1 company. The largest payer was Merck Sharp & Dohme LLC with $3,000.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 1 | $3,000 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.